The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications

Not Applicable

Not yet recruiting

• Conditions: Gastric Distress; Gastric Disease
• Interventions: Drug: OXYGEN THERAPY

• Registration Number: NCT06273319
• Lead Sponsor: Inonu University

Brief Summary

To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.

Detailed Description

Two groups of patients scheduled for gastrointestinal endoscopy will be compared in terms of desaturation and respiratory complications by applying 15 litres of oxygen therapy to the first group and 30 litres to the second group with double nasal cannula.

Study Timeline

• Study First Submitted: 2024-01-12
• Status Verified: 2024-02
• Study First Submitted QC: 2024-02-15
• Last Update Submitted: 2024-02-15
• Study First Posted: 2024-02-22
• Last Update Posted: 2024-02-22
• Study Start: 2024-03-15
• Primary Completion: 2024-05-01
• Study Completion: 2024-06-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

18-65 years old

PATIENTS WHO WILL HAVE ENDOSCOPY AND OR COLONOSCOPY

Exclusion Criteria

• Chronic obstructive pulmonary disease Having low saturation Lung cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 1: Patients who will receive 15 litres oxygen therapy	OXYGEN THERAPY	: Patients who will receive 15 litres oxygen therapy, will be applied throughout the transaction.Patient saturation and complications such as bronchospasm and laryngospasm respiratory arrest will be recorded throughout the procedure.
Group 2: Patients who will receive 30 litres oxygen therapy	OXYGEN THERAPY	Patients who will receive 30 litres oxygen therapy,will be applied throughout the transaction.Patient saturation and complications such as bronchospasm and laryngospasm respiratory arrest will be recorded throughout the procedure.

Primary Outcome Measures

Name	Time	Method
Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%	Up to 24 weeks	Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95%

Trial Locations

Locations (1)

Inonu universitesi; 🇹🇷 Malatya, Turkey